Literature DB >> 2981083

Increased adrenocorticotropin, cortisol, and arginine vasopressin secretion in primates after the antiglucocorticoid steroid RU 486: dose response relationships.

D L Healy, G P Chrousos, H M Schulte, P W Gold, G D Hodgen.   

Abstract

The antiglucocorticoid steroid, RU 486, elevated plasma ACTH concentrations when administered im at 0700 h in a dose of 1.0 mg/kg in nonhuman primates (Macaca fascicularis; P less than 0.05). The duration, but not the magnitude, of this response increased after 5.0 mg/kg RU 486 im; release of ACTH did not rise further after 10 mg/kg. Peak ACTH elevations occurred 1-2 h after RU 486 administration. Plasma cortisol concentrations peaked 4 h after RU 486 administration and the response was significant only after 5.0 mg/kg RU 486. Plasma arginine vasopressin (AVP) concentrations also increased after RU 486 but the increase occurred only after the 10.0 mg/kg dose (P less than 0.05). The AVP elevation was greatest 4 h after 10 mg/kg RU 486 and was abolished by dexamethasone pretreatment. We conclude that: 1) RU 486 elevates plasma ACTH, cortisol, and AVP concentrations in a manner which is both dose and time dependent, 2) ACTH release occurred at an order of magnitude lower dose than did AVP release, and 3) plasma AVP changes after RU 486 are glucocorticoid dependent.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981083     DOI: 10.1210/jcem-60-1-1

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  Enhancement of the ACTH response to human CRH by pretreatment with the antiglucocorticoid RU-486.

Authors:  A R Hermus; G F Pieters; G J Pesman; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockade.

Authors:  Rashmi Kumari; Lisa B Willing; Leonard S Jefferson; Ian A Simpson; Scot R Kimball
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

3.  Analgesic actions of corticotropin-releasing factor (CRF) on somatic pain sensitivity: involvement of glucocorticoid and CRF-2 receptors.

Authors:  N I Yarushkina; T R Bagaeva; L P Filaretova
Journal:  Neurosci Behav Physiol       Date:  2009-10-15

4.  Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.

Authors:  Xiaoran Zhu; Yaomeng Huang; Shuyu Li; Ning Ge; Tongxin Li; Yu Wang; Kunshen Liu; Chao Liu
Journal:  J Am Heart Assoc       Date:  2020-05-09       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.